CCP puts patient benefit over patient choice in acute merger


The Co-operation and Competition Panel has advised, for the first time, that a merger between two rival providers can go ahead, because the potential benefits outweighed the reduction in patient choice.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here